Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Guardant Health Inc
(NQ:
GH
)
31.42
+0.67 (+2.18%)
Streaming Delayed Price
Updated: 2:43 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
292,401
Open
30.80
Bid (Size)
31.40 (4)
Ask (Size)
31.44 (2)
Prev. Close
30.75
Today's Range
30.70 - 31.63
52wk Range
15.81 - 41.06
Shares Outstanding
101,298,669
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
Today 9:32 EDT
The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them.
Via
InvestorPlace
3 Precision Medicine Stocks Tailoring Treatments
July 21, 2024
With technological developments pushing the boundaries of healthcare, these are the precision medicine stocks to consider.
Via
InvestorPlace
Performance
YTD
+18.52%
+18.52%
1 Month
+6.29%
+6.29%
3 Month
+78.62%
+78.62%
6 Month
+35.31%
+35.31%
1 Year
-15.04%
-15.04%
More News
Read More
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
July 18, 2024
Via
Benzinga
Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
July 18, 2024
From
Guardant Health, Inc.
Via
Business Wire
Assessing Guardant Health: Insights From 7 Financial Analysts
July 17, 2024
Via
Benzinga
Where Guardant Health Stands With Analysts
June 28, 2024
Via
Benzinga
Evaluating Guardant Health: Insights From 5 Financial Analysts
May 24, 2024
Via
Benzinga
3 Biotech Moonshots With Imminent Catalyst Potential
July 03, 2024
Via
InvestorPlace
The 3 Best Personalized Medicine Stocks to Buy in July 2024
July 03, 2024
Via
InvestorPlace
From ‘Sell’ to ‘Strong Buy’: 3 Dramatic Analyst U-Turns to Watch
July 02, 2024
Via
InvestorPlace
Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
June 04, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
June 03, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Named to TIME100 Most Influential Companies
May 31, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening
May 30, 2024
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
May 29, 2024
Via
Benzinga
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
May 27, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 27, 2024
Via
Benzinga
Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday
May 24, 2024
Via
Benzinga
FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening
May 24, 2024
Via
Benzinga
Exposures
Product Safety
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
May 24, 2024
Via
Investor's Business Daily
Exposures
Product Safety
FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
May 23, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening
May 23, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming Investor Conferences
May 22, 2024
From
Guardant Health, Inc.
Via
Business Wire
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
May 21, 2024
Via
Benzinga
Exposures
Product Safety
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
May 21, 2024
From
Guardant Health, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.